Matrix Metalloproteinases in Kawasaki Disease
川崎病中的基质金属蛋白酶
基本信息
- 批准号:7247226
- 负责人:
- 金额:$ 10.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-15 至 2009-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffectAllelesAneurysmArterial Fatty StreakAtherosclerosisBlood VesselsBlood specimenCardiovascular DiseasesCardiovascular systemCell physiologyCellsCessation of lifeChildChildhoodClinicalClinical ResearchCoronary AneurysmCoronary arteryDataDetectionDevelopmentDiagnosticDiagnostic testsDiseaseEndopeptidasesEndothelial CellsEtiologyExtracellular MatrixExtracellular Matrix DegradationFamilyFeverGenesGenetic PolymorphismGenetic TranscriptionGoalsGrantHaplotypesInfantInjuryInterstitial CollagenaseIntracranial AneurysmIntravenous ImmunoglobulinsInvasiveLaboratoriesLeadLinkLinkage DisequilibriumMatrix Metalloproteinase InhibitorMatrix MetalloproteinasesMeasuresMediatingMedical StudentsMentorsMetalloproteinase GeneMicrosatellite RepeatsMid-Career Clinical Scientist Award (K24)Mucocutaneous Lymph Node SyndromeParentsPathogenesisPatientsPatternPlayPopulationPredispositionProteinsResearch Project GrantsResearch TrainingRoleRuptured AneurysmStudentsTestingTimeUnited StatesUnited States National Institutes of HealthVasculitisWorkdisorder preventioninsighttransmission process
项目摘要
DESCRIPTION (provided by applicant):
Kawasaki disease (KD) is the most common cause of acquired cardiovascular disease in childhood in the United States. KD presents a unique dilemma for the clinician: the disease may be difficult to recognize, there is no diagnostic laboratory test, there is an extremely effective therapy, and there is a 25% chance of serious cardiovascular damage or death if the therapy is not administered. Matrix metalloproteinases (MMPs) are secreted by cells in the vascular wall and degrade components of the extracellular matrix (ECM). MMPs have been implicated in atherosclerosis, plaque rupture, and aneurysm formation and polymorphisms in these genes have been associated with susceptibility to atherosclerosis and aneurysm formation. The short-term goals of the PI are to study children with KD as a unique population in which to explore the role of MMPs in vascular damage and the association of MMP polymorphisms with aneurysm formation. The following hypotheses will be tested: 1) MMPs play a key role in injury and remodeling of the vessel wall in children with KD, 2) Pattems of MMP activation and detection of ECM degradation products may be used as a diagnostic test for KD, and 3) Polymorphic MMP alleles are associated with increased susceptibility to KD and with aneurysm formation. This work will lead to new insights into the role of MMPs in KD and general mechanisms of aneurysm formation. Data from this project will be used to determine if there is a role for MMP inhibitors in the treatment of children with KD. The long-term goals of the PI are to understand the pathogenesis and etiology of KD, which will lead to more specific treatment strategies and disease prevention. The PI will mentor two new fellows in clinical research projects related to treatment of IVIG non-responders and non-invasive studies of endothelial cell function. Other trainees (graduate and medical students) will be involved in KD-related clinical projects. The PI will mentor two new UCSD medical students each summer on the NIH Student Research training grant at UCSD. This K24 award will allow the PI to relinquish administrative responsibilities and to share clinical responsibilities with the fellows to allow more time for mentoring activities.
描述(由申请人提供):
川崎病 (KD) 是美国儿童获得性心血管疾病的最常见原因。 KD 给临床医生带来了一个独特的困境:这种疾病可能难以识别,没有诊断性实验室测试,没有极其有效的治疗方法,如果不进行治疗,有 25% 的机会出现严重心血管损害或死亡。基质金属蛋白酶 (MMP) 由血管壁细胞分泌并降解细胞外基质 (ECM) 的成分。 MMP 与动脉粥样硬化、斑块破裂和动脉瘤形成有关,这些基因的多态性与动脉粥样硬化和动脉瘤形成的易感性相关。 PI 的短期目标是将患有川崎病的儿童作为一个独特的人群进行研究,以探索 MMP 在血管损伤中的作用以及 MMP 多态性与动脉瘤形成的关系。将测试以下假设:1) MMP 在 KD 儿童血管壁损伤和重塑中发挥关键作用,2) MMP 激活模式和 ECM 降解产物检测可用作 KD 的诊断测试,以及3) 多态性 MMP 等位基因与 KD 易感性增加和动脉瘤形成相关。这项工作将为 MMP 在 KD 中的作用和动脉瘤形成的一般机制带来新的见解。该项目的数据将用于确定 MMP 抑制剂在治疗川崎病儿童中是否有效。 PI的长期目标是了解川崎病的发病机制和病因,这将有助于制定更具体的治疗策略和疾病预防。 PI 将指导两名新研究员从事与 IVIG 无反应者治疗和内皮细胞功能非侵入性研究相关的临床研究项目。其他学员(研究生和医学生)将参与与 KD 相关的临床项目。每年夏天,PI 将利用 UCSD 的 NIH 学生研究培训补助金指导两名新的 UCSD 医学生。 K24 奖项将允许 PI 放弃行政责任,并与研究员分担临床责任,以便有更多时间进行指导活动。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JANE C BURNS其他文献
JANE C BURNS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JANE C BURNS', 18)}}的其他基金
Diagnosing and predicting risk in children with SARS-CoV-2- related illness
诊断和预测患有 SARS-CoV-2 相关疾病的儿童的风险
- 批准号:
10732857 - 财政年份:2021
- 资助金额:
$ 10.74万 - 项目类别:
Diagnosing and predicting risk in children with SARS-CoV-2- related illness
诊断和预测患有 SARS-CoV-2 相关疾病的儿童的风险
- 批准号:
10847801 - 财政年份:2021
- 资助金额:
$ 10.74万 - 项目类别:
Diagnosing and predicting risk in children with SARS-CoV-2- related illness
诊断和预测患有 SARS-CoV-2 相关疾病的儿童的风险
- 批准号:
10271147 - 财政年份:2021
- 资助金额:
$ 10.74万 - 项目类别:
Diagnosing and predicting risk in children with SARS-CoV-2- related illness
诊断和预测患有 SARS-CoV-2 相关疾病的儿童的风险
- 批准号:
10653509 - 财政年份:2021
- 资助金额:
$ 10.74万 - 项目类别:
Diagnosing and predicting risk in children with SARS-CoV-2- related illness
诊断和预测患有 SARS-CoV-2 相关疾病的儿童的风险
- 批准号:
10320983 - 财政年份:2021
- 资助金额:
$ 10.74万 - 项目类别:
Diagnosing and predicting risk in children with SARS-CoV-2- related illness
诊断和预测患有 SARS-CoV-2 相关疾病的儿童的风险
- 批准号:
10849054 - 财政年份:2021
- 资助金额:
$ 10.74万 - 项目类别:
Innate Immune Activation and Endothelial Cell Dysfunction in Acute Kawasaki Disease
急性川崎病的先天免疫激活和内皮细胞功能障碍
- 批准号:
10064100 - 财政年份:2018
- 资助金额:
$ 10.74万 - 项目类别:
Endothelial Cell and Cardiomyocyte Dysfunction in Children with Kawasaki disease-like SARS-CoV-2 Induced Immune Activation
类川崎病 SARS-CoV-2 诱导的免疫激活儿童的内皮细胞和心肌细胞功能障碍
- 批准号:
10165329 - 财政年份:2018
- 资助金额:
$ 10.74万 - 项目类别:
Innate Immune Activation and Endothelial Cell Dysfunction in Acute Kawasaki Disease
急性川崎病的先天免疫激活和内皮细胞功能障碍
- 批准号:
10311990 - 财政年份:2018
- 资助金额:
$ 10.74万 - 项目类别:
Impact of TNFa blockade on immune function in acute Kawasaki disease
TNFa阻断对急性川崎病免疫功能的影响
- 批准号:
7943445 - 财政年份:2010
- 资助金额:
$ 10.74万 - 项目类别:
相似国自然基金
KIR3DL1等位基因启动子序列变异影响其差异表达的分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NUP205双等位基因突变影响纤毛发生而致内脏转位合并先天性心脏病的机理研究
- 批准号:
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
全基因组范围内揭示杂交肉兔等位基因特异性表达模式对杂种优势遗传基础的影响
- 批准号:32102530
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
等位基因不平衡表达对采后香蕉果实后熟与品质形成的影响
- 批准号:31972471
- 批准年份:2019
- 资助金额:57 万元
- 项目类别:面上项目
高温影响水稻不同Wx等位基因表达及直链淀粉含量的分子机制研究
- 批准号:31500972
- 批准年份:2015
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Systems Genetics of Cocaine Preference in Drosophila
果蝇可卡因偏好的系统遗传学
- 批准号:
10675195 - 财政年份:2023
- 资助金额:
$ 10.74万 - 项目类别:
MicroRNA lipid-nanoparticle based therapy targets neuroinflammation and ApoE dysregulation in Alzheimer’s disease
基于 MicroRNA 脂质纳米颗粒的疗法针对阿尔茨海默病中的神经炎症和 ApoE 失调
- 批准号:
10667157 - 财政年份:2023
- 资助金额:
$ 10.74万 - 项目类别:
Protein tyrosine phosphatase non-receptor 14 in vascular stability and remodeling
蛋白酪氨酸磷酸酶非受体 14 在血管稳定性和重塑中的作用
- 批准号:
10660507 - 财政年份:2023
- 资助金额:
$ 10.74万 - 项目类别:
Distinct Glycophenotypes with Abnormal Signaling Define a Subpopulation of B cells Responsible for Production of Galactose-Deficient IgA1, the Main Autoantigen in IgA Nephropathy
具有异常信号传导的独特糖表型定义了负责产生半乳糖缺陷型 IgA1(IgA 肾病的主要自身抗原)的 B 细胞亚群
- 批准号:
10563618 - 财政年份:2023
- 资助金额:
$ 10.74万 - 项目类别:
Cellular crosstalk regulating cholangiocyte proliferation following extrahepatic bile duct injury
细胞串扰调节肝外胆管损伤后胆管细胞增殖
- 批准号:
10648254 - 财政年份:2023
- 资助金额:
$ 10.74万 - 项目类别: